Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Colorectal cancer » Deaths
 

Deaths from Colorectal cancer

Colorectal cancer: Deaths

Deaths from Colorectal cancer: 57,200 deaths in USA 1999 (CDC)

Death Rate Extrapolation

Death rate extrapolations for USA for Colorectal cancer: 57,199 per year, 4,766 per month, 1,099 per week, 156 per day, 6 per hour, 0 per minute, 0 per second. Note: this automatic extrapolation calculation uses the deaths statistic: 57,200 deaths in USA 1999 (CDC)

Survival rate statistics for Colorectal cancer

The following are statistics from various sources about the survival rate for Colorectal cancer:

  • 59.2% of people with colon and rectal cancer survive after 5 years in the US 1983-90 (SEER)
  • 63% of white people survive 5 years for colon cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 53% of African American people survive 5 years for colon cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% survive 5 years for colon cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% of white people survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 53% of African American people survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5-year survival rate for black people with colon and rectal cancer is 49.5% in the US 1983-90 (SEER)
  • 5-year survival rate for people with colon and rectal cancer is 59.2% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with colon and rectal cancer is 60.1% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with colon cancer is 64.1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with colon cancer is 42.1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with colon cancer is 79% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with colon cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with colon cancer is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with colon cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with colon cancer is 73% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with colon cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with colon cancer is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with colon cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with colon cancer is 63% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with colon cancer is 42% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with colon cancer is 53% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with colon cancer is 36% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with colon cancer is 63.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with colon cancer is 42.8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with colon cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with colon cancer is 59% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with colon cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with colon cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with colon cancer is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with colon cancer is 47% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with colon cancer is 70% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with colon cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with colon cancer is 63% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with colon cancer is 43% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with colon cancer is 48% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with colon cancer is 34% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-99 with rectum cancer is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with rectum cancer is 40.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with rectum cancer is 79% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with rectum cancer is 51% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with rectum cancer is 80% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with rectum cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with rectum cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with rectum cancer is 45% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with rectum cancer is 74% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with rectum cancer is 43% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with rectum cancer is 67% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with rectum cancer is 40% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with rectum cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with rectum cancer is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with rectum cancer is 71.4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with rectum cancer is 44.8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with rectum cancer is 87% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with rectum cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with rectum cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with rectum cancer is 53% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with rectum cancer is 82% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with rectum cancer is 52% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with rectum cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with rectum cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with rectum cancer is 70% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with rectum cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with rectum cancer is 54% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with rectum cancer is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 7 months is the median survival for patients with advanced colorectal cancer at time of diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • 16 months is the median survival for patients with advanced colorectal who are still alive two years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • Nearly 6 years is the median survival for patients with advanced colorectal who are still alive five years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)

Colorectal cancer: Life Years Lost

Average life years lost from Colorectal cancer: 13.4 years for colon/rectum cancer (SEER)1

Misdiagnosis and Colorectal cancer deaths

Colorectal cancer can be deadly if misdiagnosed...more »

Death statistics for Colorectal cancer

The following are statistics from various sources about deaths and Colorectal cancer:

  • 57,155 deaths reported in USA 1999 (NVSR Sep 2001)
  • 56,730 estimated deaths for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 28,320 estimated male deaths for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 28,410 estimated female deaths for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Third leading cause of cancer deaths in women in the US (Cancer Facts and Figures, American Cancer Society, 2004)
  • 28,800 deaths in women in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 16.4 per 100,000 population of white Americans 1996 (CBCF Health Organisation, 2004)
  • 22.5 per 100,000 population of black Americans 1996 (CBCF Health Organisation, 2004)
  • 55.3 per 100,000 people in USA 2001 (NCHS, 2003)
  • 24.2 per 100,000 men died from colorectal cancer in USA 2001 (NCHS, 2003)
  • 17.2 per 100,000 women died from colorectal cancer in USA 2001 (NCHS, 2003)
  • Colorectal cancer death statistics by racial group in the USA:
    • 25.3 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 34.6 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 15.8 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 18.5 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 18.4 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 17.5 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 24.6 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.0 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 12.1 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.4 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.6 per 100,000 Asian/Pacific Islander people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 12.0 per 100,000 American Indian or Alaska Native people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 14.1 per 100,000 Hispanic/Latino people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 19.6 per 100,000 white people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 27.6 per 100,000 black people died from colorectal cancer in USA 2001 (NCHS, 2003)
  • 4,500 deaths in men from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 3,900 deaths in women from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 27 per 100,000 deaths in men from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 17 per 100,000 deaths in women from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Mortality rates for colorectal cancer deaths in various countries:
    • 15.9 men per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.0 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.1 men per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.4 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 23.0 men per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.9women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.4 men per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.8 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.8 men per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.0 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.4 men per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.6 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.0 men per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.1 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.2 men per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.3 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.1 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 24.8 men per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.0 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.4 men per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.4 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 34.2 men per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.5 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 23.8 men per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.5 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.7 men per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.0 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.5 men per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.5 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.3men per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.1 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 21.7 men per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.0 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.4 men per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.7 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 33.5 men per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.9 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 22.6 men per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.4 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 19.7 men per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.3 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.6 men per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.0 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.2 men per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.6 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.9 men per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.7 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.9 men per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000196.7 American Cancer Society)
    • 13.3 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.0 men per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.7 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.2 men per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.8 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 men per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.6 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 19.0 men per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.0 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 25.7 men per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.2 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 22.0 men per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.0 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.6 men per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.6 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.5 men per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.3 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.9 men per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.6 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.4 men per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.2 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.5 men per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.7 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.5 men per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 28.0 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.1 men per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 25.1 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.3 men per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.1 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.4 men per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.5 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.5 men per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.7 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 men per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.1 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.7 men per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.8 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.1 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • 2,201 women died from colorectal cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 2,448 men died from colorectal cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 20 women per 100,000 population die of colorectal cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • 28 men per 100,000 population die of colorectal cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • 3.4% of all female deaths was due colorectal cancer to in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 3.6% of all male deaths was due to colorectal cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Death statistics by state in Australia:
    • Colorectal cancer caused 31.2 male deaths per 100,000 population in New South Wales 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 34.8 male deaths per 100,000 population in Victoria 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 33.4 male deaths per 100,000 population in Queensland 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 35.1 male deaths per 100,000 population in Western Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 34.7 male deaths per 100,000 population in South Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 35.4 male deaths per 100,000 population in Tasmania 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 33.7 male deaths per 100,000 population in Australian Capital Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 17.7 male deaths per 100,000 population in Northern Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 20.6 female deaths per 100,000 population in New South Wales 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 23.2 female deaths per 100,000 population in Victoria 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 23 female deaths per 100,000 population in Queensland 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 21.9 female deaths per 100,000 population in Western Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 22.3 female deaths per 100,000 population in South Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 31.4 female deaths per 100,000 population in Tasmania 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 24.7 female deaths per 100,000 population in Australian Capital Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 15.7 female deaths per 100,000 population in Northern Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
  • Colorectal cancer caused 2,149 female deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 13.9% of female cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 20.2 female deaths per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer caused 2,569 male deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 12.8% of male cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 31 deaths from colorectal cancer per 100,000 population occurred in men in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)

Deaths from Colorectal cancer: medical news summaries

The following medical news items are relevant to death from Colorectal cancer:

Colorectal cancer: Hospitalization Statistics

The following are statistics from various sources about hospitalizations and Colorectal cancer:

  • 0.75% (95,420) of hospital consultant episodes were for malignant neoplasm of colon in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 92% of hospital consultant episodes for malignant neoplasm of colon required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 55% of hospital consultant episodes for malignant neoplasm of colon were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • more stats »

Premium articles about Death:

This section lists our premium articles on topics related to death. These are original authored articles on topics of great interest:



Footnotes:
1. SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise